SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-254536
Filing Date
2017-08-10
Accepted
2017-08-10 16:32:00
Documents
60
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d414775d10q.htm 10-Q 345304
2 EX-31.1 d414775dex311.htm EX-31.1 9245
3 EX-31.2 d414775dex312.htm EX-31.2 9295
4 EX-32.1 d414775dex321.htm EX-32.1 4436
  Complete submission text file 0001193125-17-254536.txt   3047977

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crsp-20170630.xml EX-101.INS 457374
6 XBRL TAXONOMY EXTENSION SCHEMA crsp-20170630.xsd EX-101.SCH 44352
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crsp-20170630_cal.xml EX-101.CAL 56030
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crsp-20170630_def.xml EX-101.DEF 186184
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crsp-20170630_lab.xml EX-101.LAB 375089
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crsp-20170630_pre.xml EX-101.PRE 267842
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 171021847
SIC: 2836 Biological Products, (No Diagnostic Substances)